mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.6 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
Obatoclax Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.6 |